Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Armodafinil in Sleep-Deprived Healthy Subjects
NCT02468856Phase 1Completed
- Sponsor
- University of Florida
- Start
- May 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of armodafinil in Hypersomnia (HS), sponsored by University of Florida. Primary endpoint: Effect of armodafinil on simulated driving at 24 hours. Started May 2017; status: completed.
02
Drugs
armodafinil
03
Conditions
Hypersomnia (HS)
Beyond the preview
Go deeper on NCT02468856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02468856.